once weekly glp 1 agonist GLP-1 Agonists - What is it? Comparing Ozempic, Wegovy and Other

Notably, these pooled analyses included limited patients treated with semaglutide or tirzepatide

Consequent to these results, dulaglutide obtained FDA permission for administration in individuals with an eGFR as low as 15 mL/min per 1.73 m2 (Tuttle et al

Effect of Semaglutide on Cardiac Structure and Function in Patients With Obesity-Related Heart Failure

External resources PubMed - Weight regain after GLP-1 RA interruption: narrative review eClinicalMedicine - Metabolic rebound after GLP-1 RA discontinuation: meta-analysis For researchers navigating the complexities of GLP-1 treatment duration, SeekPeptides provides comprehensive protocol guides, dosing calculators , and evidence-based resources designed to help you make informed decisions about your treatment timeline

Claim CME for this episode HERE